RecruitingNCT05508932
Atrial Fibrillation in Beta-Thalassemia
Sponsor
University Hospital of Ferrara
Enrollment
350 participants
Start Date
Sep 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The study aims to evaluate the clinical, laboratory and instrumental differences that exist between beta-thalassemia patients with atrial fibrillation and those not affected by arrhythmia.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study looks at how often patients with beta-thalassemia (an inherited blood disorder requiring regular blood transfusions) develop atrial fibrillation — an irregular heartbeat that can increase the risk of stroke. Because repeated transfusions can cause iron to build up in the heart, these patients are at higher risk for heart problems.
**You may be eligible if...**
- You have transfusion-dependent beta-thalassemia
- You are being followed at the Cardiology Unit of the University Hospital of Ferrara
- You have had both an ECG (heart tracing) and an echocardiogram (heart ultrasound) performed
**You may NOT be eligible if...**
- You are under 18 years of age
- You are pregnant
- You are unable to give informed consent
- You have not had the required heart tests done
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05508932
Related Trials
Feasibility Study of the FARAFLEX Mapping and PFA System
NCT065105564 locations
REGistry of Long-term AnTithrombotic TherApy-2
NCT043471871 location
Optimizing Quality of Life by Improved Patient Expectation Following Atrial Fibrillation Catheter Ablation
NCT055575262 locations
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
NCT0597668528 locations
Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillation - Trigger and Substrate Guided Wide Area Radiofrequency Ablation Compared to Pulsed Field Ablation Pulmonary Vein Isolation
NCT048232992 locations